Officials maintain the changes seek to simplify approvals for research institutions, pharmaceutical and biomedical industries. Local authorities and relevant stakeholders are closely monitoring the situation as fresh developments unfold on the ground. Officials noted that further verified updates and administrative measures will be shared following a detailed review.